Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1609
    -0.0074 (-0.63%)
     
  • GBP/USD

    1.2372
    -0.0066 (-0.53%)
     
  • Bitcoin GBP

    51,883.68
    +534.09 (+1.04%)
     
  • CMC Crypto 200

    1,380.33
    +67.71 (+5.16%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.25
    +0.52 (+0.63%)
     
  • GOLD FUTURES

    2,402.90
    +4.90 (+0.20%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

AI in Drug Discovery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

AI in Drug Discovery Market – Scope of Report This report on the global AI in drug discovery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031.

New York, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "AI in Drug Discovery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" - https://www.reportlinker.com/p06184373/?utm_source=GNW
The report provides revenue of the global AI in drug discovery market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year.

The report also provides the compound annual growth rate (CAGR %) of the global AI in drug discovery market from 2021 to 2031.

The report has been prepared after an extensive research.Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers.

Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the AI in drug discovery market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global AI in drug discovery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study.Moreover, the report sheds light on the changing competitive dynamics in the global AI in drug discovery market.

These serve as valuable tools for existing market players as well as for entities interested in participating in the global AI in drug discovery market.

The report delves into the competitive landscape of the global AI in drug discovery market.Key players operating in the global AI in drug discovery market are identified and each one of these is profiled in terms of various attributes.

Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global AI in drug discovery market profiled in this report.

Key Questions Answered in AI in Drug Discovery Market Report

What is the sales/revenue generated by the AI in drug discovery market across all regions during the forecast period?
What are the opportunities in the global AI in drug discovery market?
What are the major drivers, restraints, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which drug type segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

AI in Drug Discovery Market – Research Objectives and Research Approach
The comprehensive report on the global AI in drug discovery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones.The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed.

Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global AI in drug discovery market in terms of offering, technology, drug type, application, end user, and region.Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided.

Such valuable insights enable market stakeholders in making informed business decisions for investment in the global AI in drug discovery market.
Read the full report: https://www.reportlinker.com/p06184373/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001